These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 30818786)

  • 21. Synergistic effects of curcumin and its analogs with other bioactive compounds: A comprehensive review.
    Hosseini-Zare MS; Sarhadi M; Zarei M; Thilagavathi R; Selvam C
    Eur J Med Chem; 2021 Jan; 210():113072. PubMed ID: 33310285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin-based anti-prostate cancer agents.
    Chen QH
    Anticancer Agents Med Chem; 2015; 15(2):138-56. PubMed ID: 25594891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An update on Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Bar-Sela G
    Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potential and limitations of curcumin as antimetastatic agent.
    Dytrych P; Kejík Z; Hajduch J; Kaplánek R; Veselá K; Kučnirová K; Skaličková M; Venhauerová A; Hoskovec D; Martásek P; Jakubek M
    Biomed Pharmacother; 2023 Jul; 163():114758. PubMed ID: 37141738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of New Improved Curcumin Derivatives to Multi-targets of Cancer and Inflammation.
    Harikrishnan A; Khanna S; Veena V
    Curr Drug Targets; 2021; 22(5):573-589. PubMed ID: 32753008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives.
    Xu XY; Meng X; Li S; Gan RY; Li Y; Li HB
    Nutrients; 2018 Oct; 10(10):. PubMed ID: 30347782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular targets of curcumin in breast cancer (Review).
    Song X; Zhang M; Dai E; Luo Y
    Mol Med Rep; 2019 Jan; 19(1):23-29. PubMed ID: 30483727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of apoptosis by curcumin and its implications for cancer therapy.
    Karunagaran D; Rashmi R; Kumar TR
    Curr Cancer Drug Targets; 2005 Mar; 5(2):117-29. PubMed ID: 15810876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Fluorescence-Labeled Curcumin Conjugate: Synthesis, Evaluation and Imaging on Human Cell Lines.
    Sheikh S; Sturzu A; Kalbacher H; Nagele T; Weidenmaier C; Horger M; Schwentner C; Ernemann U; Heckl S
    Curr Pharm Des; 2018; 24(16):1821-1826. PubMed ID: 29623828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress.
    Martinez-Cifuentes M; Weiss-Lopez B; Santos LS; Araya-Maturana R
    Curr Top Med Chem; 2015; 15(17):1663-72. PubMed ID: 25915614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2.
    Banerjee S; Ji C; Mayfield JE; Goel A; Xiao J; Dixon JE; Guo X
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8155-8160. PubMed ID: 29987021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms of curcumin action: signal transduction.
    Shehzad A; Lee YS
    Biofactors; 2013; 39(1):27-36. PubMed ID: 23303697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin in Treating Breast Cancer: A Review.
    Wang Y; Yu J; Cui R; Lin J; Ding X
    J Lab Autom; 2016 Dec; 21(6):723-731. PubMed ID: 27325106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin Nanoparticles as Promising Therapeutic Agents for Drug Targets.
    Chopra H; Dey PS; Das D; Bhattacharya T; Shah M; Mubin S; Maishu SP; Akter R; Rahman MH; Karthika C; Murad W; Qusty N; Qusti S; Alshammari EM; Batiha GE; Altalbawy FMA; Albooq MIM; Alamri BM
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443593
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic Applications of Curcumin Nanoformulations.
    Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
    AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular targets for the management of cancer using Curcuma longa Linn. phytoconstituents: A Review.
    Sultana S; Munir N; Mahmood Z; Riaz M; Akram M; Rebezov M; Kuderinova N; Moldabayeva Z; Shariati MA; Rauf A; Rengasamy KRR
    Biomed Pharmacother; 2021 Mar; 135():111078. PubMed ID: 33433356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in curcumin nanoformulation for cancer therapy.
    Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
    Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
    Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin nanoformulations: a future nanomedicine for cancer.
    Yallapu MM; Jaggi M; Chauhan SC
    Drug Discov Today; 2012 Jan; 17(1-2):71-80. PubMed ID: 21959306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Zidan J; Bar Sela G
    Curr Opin Clin Nutr Metab Care; 2011 Nov; 14(6):588-97. PubMed ID: 21986478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.